Edward Doerffler
23Patents
13h-index
60Co-inventors
80Inventor score
Filing activity: Dec 29, 2004 → Feb 17, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9388208B2 | Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections | Chemistry; Metallurgy | 47 | Active |
| US9724360B2 | Methods for treating Filoviridae virus infections | Emerging Cross-Sectional Technologies | 47 | Active |
| US9701682B2 | Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections | Chemistry; Metallurgy | 43 | Active |
| US10059716B2 | Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections | Chemistry; Metallurgy | 42 | Active |
| US9949994B2 | Methods for treating Filoviridae virus infections | Emerging Cross-Sectional Technologies | 42 | Active |
| US10377761B2 | Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections | Chemistry; Metallurgy | 37 | Active |
| US10251898B2 | Methods for treating Filoviridae virus infections | Emerging Cross-Sectional Technologies | 35 | Active |
| US10695357B2 | Methods for treating filoviridae virus infections | Emerging Cross-Sectional Technologies | 27 | Active |
| US11266666B2 | Methods for treating Filoviridae virus infections | Emerging Cross-Sectional Technologies | 23 | Active |
| US8884030B2 | Inhibitors of Flaviviridae viruses | Emerging Cross-Sectional Technologies | 21 | Active |
| US8524764B2 | Inhibitors of Flaviviridae viruses | Emerging Cross-Sectional Technologies | 20 | Active |
| US11344565B2 | Methods for the preparation of ribosides | Emerging Cross-Sectional Technologies | 18 | Active |
| US7893264B2 | Antiviral phosphinate compounds | Human Necessities | 13 | Active |
| US7553825B2 | Anti-proliferative compounds, compositions, and methods of use thereof | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8268802B2 | Anti-proliferative compounds, compositions, and methods of use thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US8569302B2 | Inhibitors of flaviviridae viruses | Chemistry; Metallurgy | 3 | Active |
| US8501714B2 | Inhibitors of Flaviviridae viruses | Chemistry; Metallurgy | 3 | Active |
| US8765722B2 | Inhibitors of flaviviridae viruses | Chemistry; Metallurgy | 2 | Active |
| US8741946B2 | Inhibitors of flaviviridae viruses | Human Necessities | 1 | Active |
| US12054507B2 | Antiviral compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US8674088B2 | Antiviral phosphinate compounds | Human Necessities | 0 | Active |
| US8586744B2 | Antiviral phosphinate compounds | Human Necessities | 0 | Active |
| US8927484B2 | Antiviral compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.